The Ensign Group Inc (ENSG)

Return on equity (ROE)

Dec 31, 2023 Dec 31, 2022 Dec 31, 2021 Dec 31, 2020 Dec 31, 2019
Net income US$ in thousands 209,399 224,681 194,652 170,478 110,534
Total stockholders’ equity US$ in thousands 1,491,860 1,247,330 1,020,770 818,077 654,197
ROE 14.04% 18.01% 19.07% 20.84% 16.90%

December 31, 2023 calculation

ROE = Net income ÷ Total stockholders’ equity
= $209,399K ÷ $1,491,860K
= 14.04%

Ensign Group Inc's return on equity (ROE) has exhibited a decreasing trend over the past five years. The ROE decreased from 16.90% in 2019 to 14.04% in 2023. This downward trend suggests that the company's ability to generate profit from its shareholder equity has weakened over the period.

A declining ROE could be due to various factors such as decreasing profitability, increasing debt levels, or inefficient utilization of assets. It is important for stakeholders to closely monitor the reasons behind the decreasing ROE to assess the company's financial health and sustainability.

Further analysis of Ensign Group Inc's financial statements and performance metrics is recommended to gain a comprehensive understanding of the factors influencing its ROE and to make informed investment decisions.


Peer comparison

Dec 31, 2023

Company name
Symbol
ROE
The Ensign Group Inc
ENSG
14.04%
National HealthCare Corporation
NHC
7.35%